OTCMKTS:VRTC Veritec (VRTC) Stock Forecast, Price & News $0.03 0.00 (0.00%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$0.03▼$0.0350-Day Range$0.02▼$0.0352-Week Range$0.02▼$0.04Volume1,900 shsAverage Volume4,308 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest About Veritec (OTCMKTS:VRTC) StockVeritec, Inc. engages in the development, sales, and licensing of products. It also provides services related to mobile banking solutions. The firm also operates in back-end cardholder transaction processing services for visa-branded card programs on behalf of its sponsoring bank. The company was founded on September 8, 1982 and is headquartered in Golden Valley, MN.Read More Receive VRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Veritec and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTC Stock News HeadlinesJune 9, 2023 | finance.yahoo.comIs Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?June 3, 2023 | msn.comWall Street Says This Growth Stock Is a Buy, but Is It Overvalued?June 9, 2023 | Chaikin Analytics (Ad)Wall Street legend warns: "A new dawn is coming"He called the Priceline collapse in 2012, the 2020 crash, and the 2022 bear market. Now he says a new dawn is coming to U.S. stocks. It's time to throw out the investment blueprint of the last decade and prepare for a massive shift. If you've lost money over the past two years, this changes everything.May 31, 2023 | finance.yahoo.comWhy Is Vertex (VRTX) Down 6% Since Last Earnings Report?May 30, 2023 | msn.comCantor Fitzgerald Reiterates Vertex Pharmaceuticals (VRTX) Overweight RecommendationMay 30, 2023 | msn.comWilliam Blair Initiates Coverage of Vertex Pharmaceuticals (VRTX) with Outperform RecommendationMay 30, 2023 | finance.yahoo.comVertex to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 13May 30, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ) and COMPASS Pathways (CMPS)June 9, 2023 | Chaikin Analytics (Ad)Wall Street legend warns: "A new dawn is coming"He called the Priceline collapse in 2012, the 2020 crash, and the 2022 bear market. Now he says a new dawn is coming to U.S. stocks. It's time to throw out the investment blueprint of the last decade and prepare for a massive shift. If you've lost money over the past two years, this changes everything.May 23, 2023 | finance.yahoo.comVERITEC SIGNED JOINT VENTURE WITH VIVA ENTERTAINMENT GROUP AKA VIVALIVETV (OTTV)May 18, 2023 | msn.comCrispr Therapeutics: Potential Beyond Current BLA Filing Of Exa-CelMay 18, 2023 | finance.yahoo.comHere’s Why Vertex Pharmaceuticals Incorporated (VRTX) Outperformed in Q1May 11, 2023 | finance.yahoo.comHere's Why We Think Vertex Pharmaceuticals (NASDAQ:VRTX) Might Deserve Your Attention TodayMay 7, 2023 | dallasnews.comMotley Fool: Vertex Pharmaceuticals makes products people can’t do withoutMay 7, 2023 | finance.yahoo.comVertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?May 4, 2023 | msn.comVertex assumed Overweight at Piper Sandler despite recent rallyMay 4, 2023 | marketwatch.comVertex Pharmaceuticals Inc. stock rises Thursday, outperforms marketMay 4, 2023 | realmoney.thestreet.comVertex Pharmaceuticals Continues Its Impressive Rally: How to Play ItMay 4, 2023 | msn.comMaxim Group Maintains Vertex Pharmaceuticals (VRTX) Buy RecommendationMay 3, 2023 | benzinga.comVertex Pharmaceuticals, Transocean, And 'One Of The Best Companies' In Staples: CNBC's 'Final Trades'May 2, 2023 | msn.comTruist Securities Maintains Vertex Pharmaceuticals (VRTX) Buy RecommendationMay 2, 2023 | msn.comRBC Capital Maintains Vertex Pharmaceuticals (VRTX) Sector Perform RecommendationMay 2, 2023 | msn.comOppenheimer Maintains Vertex Pharmaceuticals (VRTX) Outperform RecommendationMay 2, 2023 | msn.comStifel Maintains Vertex Pharmaceuticals (VRTX) Hold RecommendationMay 2, 2023 | msn.comVertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVieApril 30, 2023 | americanbankingnews.comVeritec (OTCMKTS:VRTC) and Franklin Covey (NYSE:FC) Financial ContrastApril 29, 2023 | marketwatch.comVertex Pharmaceuticals Inc. stock rises Friday, still underperforms marketSee More Headlines VRTC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRTC Company Calendar Last Earnings5/11/2023Today6/09/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolOTCMKTS:VRTC CUSIP923437305 CIK773318 Webwww.veritecinc.com Phone(763) 253-2670Fax763-253-0503Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-510,000.00 Net Margins-234.35% Pretax Margin-234.35% Return on EquityN/A Return on Assets-586.48% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual Sales$350,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.19) per share Price / Book-0.14Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-22.54 Key ExecutivesVan Thuy TranChairman, Chief Executive Officer & TreasurerKey CompetitorsRainmaker SystemsOTCMKTS:VCTL(UPGI)OTCMKTS:UPGI01 Communique LaboratoryOTCMKTS:OCQLF1mage SoftwareOTCMKTS:ISOL24SevenOffice Group AB (publ)OTCMKTS:TFSVFView All Competitors VRTC Stock - Frequently Asked Questions How have VRTC shares performed in 2023? Veritec's stock was trading at $0.0230 at the beginning of the year. Since then, VRTC shares have increased by 17.4% and is now trading at $0.0270. View the best growth stocks for 2023 here. How were Veritec's earnings last quarter? Veritec, Inc. (OTCMKTS:VRTC) announced its earnings results on Thursday, May, 11th. The company reported ($0.01) earnings per share for the quarter. The firm earned $0.09 million during the quarter. What other stocks do shareholders of Veritec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Veritec investors own include Weyerhaeuser (WY), Caterpillar (CAT), Ctrip.Com International (CTRP), Deere & Company (DE), HashiCorp (HCP), Honda Motor (HMC), Simon Property Group (SPG), Suzuki Motor (SZKMY), Real Estate Select Sector SPDR Fund (XLRE) and Applied Optoelectronics (AAOI). What is Veritec's stock symbol? Veritec trades on the OTCMKTS under the ticker symbol "VRTC." How do I buy shares of Veritec? Shares of VRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Veritec's stock price today? One share of VRTC stock can currently be purchased for approximately $0.03. How can I contact Veritec? Veritec's mailing address is 2445 Winnetka Avenue N., Golden Valley MN, 55427. The official website for the company is www.veritecinc.com. The company can be reached via phone at (763) 253-2670 or via fax at 763-253-0503. This page (OTCMKTS:VRTC) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veritec, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.